Chirality of a 1,10-bisacetoxymitosene compound. Impact on reductive activation, DNA interstrand cross-linking and antitumour activity

M. Maliepaard; S.E. Groot; N.J. de Mol; L.H.M. Janssen; M. Freriks; Willem Verboom; David Reinhoudt; I.J. Stratford

Chirality of a 1,10-bisacetoxymitosene compound. Impact on reductive activation, DNA interstrand cross-linking and antitumour activity

M. Maliepaard, S.E. Groot, N.J. de Mol, L.H.M. Janssen, M. Freriks, Willem Verboom, David Reinhoudt, I.J. Stratford

Research output: Contribution to journal › Article › Academic › peer-review

114 Downloads (Pure)

Original language	Undefined
Pages (from-to)	403-413
Journal	Anti-cancer drug design
Volume	11
Issue number	11
Publication status	Published - 1996

Keywords

METIS-105919
IR-10950

Access to Document

7807

Cite this

@article{6c964d10761a4287b28db2d8a0a71f5c,

title = "Chirality of a 1,10-bisacetoxymitosene compound. Impact on reductive activation, DNA interstrand cross-linking and antitumour activity",

keywords = "METIS-105919, IR-10950",

author = "M. Maliepaard and S.E. Groot and {de Mol}, N.J. and L.H.M. Janssen and M. Freriks and Willem Verboom and David Reinhoudt and I.J. Stratford",

year = "1996",

language = "Undefined",

volume = "11",

pages = "403--413",

journal = "Anti-cancer drug design",

issn = "0266-9536",

publisher = "Cognizant Communication Corporation",

number = "11",

}

TY - JOUR

T1 - Chirality of a 1,10-bisacetoxymitosene compound. Impact on reductive activation, DNA interstrand cross-linking and antitumour activity

AU - Maliepaard, M.

AU - Groot, S.E.

AU - de Mol, N.J.

AU - Janssen, L.H.M.

AU - Freriks, M.

AU - Verboom, Willem

AU - Reinhoudt, David

AU - Stratford, I.J.

PY - 1996

Y1 - 1996

KW - METIS-105919

KW - IR-10950

M3 - Article

SN - 0266-9536

VL - 11

SP - 403

EP - 413

JO - Anti-cancer drug design

JF - Anti-cancer drug design

IS - 11

ER -